Texas Cardiac Arrhythmia Institute at St. David's Medical Center to host international conference on complex cardiac arrhythmias

Texas Cardiac Arrhythmia Institute at St. David's Medical Center

PR96103

 

AUSTIN, Texas, May 20, 2022 /PRNewswire=KYODO JBN/ --

 

EPLive 2022 is a two-day conference that draws the world's top cardiac

electrophysiology experts

 

 

On June 2 and 3, 2022, the Texas Cardiac Arrhythmia Institute (TCAI) at St.

David's Medical Center will host its sixth international symposium on complex

arrhythmias, EPLive 2022.

 

 

EPLive is an intensive, two-day educational meeting for practicing clinical

cardiac electrophysiologists, electrophysiologist fellows and general

cardiologists who have an interest in treating complex cardiac arrhythmias, a

condition in which the heart beats with an irregular or abnormal rhythm. Live

cases broadcast from the new, state-of-the-art Electrophysiology Center at St.

David's Medical Center, with expert commentary, will serve as the primary

teaching tool.

 

 

"We are honored to host our first in-person conference at the new world-class

Electrophysiology Center, which has six electrophysiology labs equipped with

the latest technology," Andrea Natale, M.D., F.H.R.S., F.A.C.C., F.E.S.C.,

cardiac electrophysiologist and executive medical director of TCAI and EPLive

course director, said. "By sharing live cases, we can more efficiently make

advances in the procedures and technologies for the treatment of complex

arrhythmias, further enhancing patient care across the globe."

 

 

Cardiac arrhythmias are caused by problems with the heart's electrical system.

Many cardiac arrhythmias are treated using modern ablation procedures, which

involve burning, freezing or neutralizing portions of the heart muscle where

abnormal electrical pulses set off the irregular heartbeats. EPLive is designed

to help attendees gain a better understanding of techniques used to treat

atrial and ventricular arrhythmias, implant complex devices and extract

malfunctioning devices.

 

 

EPLive consists of four sections: Atrial Fibrillation (A Fib) ablation,

Ventricular Tachycardia (VT) ablation, Devices, and New Technology. The

sessions consist of a combination of live and recorded cases from TCAI and some

of the world's premier centers: Arrhythmia Center CardioInfantil Foundation

(Colombia), Bengaluru (India), Cleveland Clinic, Kansas City Heart Rhythm

Institute, Mass General Hospital, MedStar Heart & Vascular Institute (Texas),

Methodist Hospital (Houston, Texas), Monzino Cardiology Center (Italy), Mt.

Sinai Hospital (New York), Northwell Health (New York), Pacific Heart

(California), Penn Heart and Vascular Center, UCLA, University of Arkansas

Medical Center, University of Chicago Medicine, University of Colorado School

of Medicine, University of Pennsylvania, University of Texas Southwestern

Medical Center, Vanderbilt University and Westside Regional Medical Center

(Florida).

 

 

Cases include procedures such as A Fib ablation and ablation of post-A Fib

atrial arrhythmias, VT ablation (endocardial and epicardial), balloon cases

(cryo, Apama and laser), CRT implants, SQ ICD and lead extraction and

venoplasty. Additionally, EPLive will feature new technology pioneered by

physicians at TCAI, including electroporation and leadless dual chamber pacing.

 

 

The conference will also focus on a variety of objectives, including:

 

 

     -        Outlining and applying techniques used to map and ablate atrial

        arrhythmias.

     -        Identifying processes to reduce complications and promote safety

        measures for the patient during ablation of atrial fibrillation.

     -        Demonstrating understanding of the latest evidence and guidelines      

        in arrhythmia management and treatment with new technology.

     -        Applying approaches that best utilize the new technologies  

        demonstrated to optimize clinical outcomes.

     -        Identifying processes that can benefit from the integration of new

        technologies and promote safer procedures for the patient.

     -        Identifying processes to reduce complications and promote safety

        measures for the patient during lead extractions.

 

In addition to demonstrations by Dr. Natale, EPLive will feature presentations

by a number of TCAI physicians, including course co-director, Amin Al-Ahmad,

M.D., as well as Shane Bailey, M.D.; Mohamed Bassiouny, M.D.; David Burkhardt,

M.D.; David Burkland, M.D.; Robert Canby, M.D.; Joseph Gallinghouse, M.D.;

Brian Greet, M.D.; Eric M. Hoenicke, M.D.; Rodney Horton, M.D.; Patrick

Hranitzky, M.D.; Javier Sanchez, M.D.; Kamala Tamirisa, M.D.; Senthil

Thambidorai, M.D.; David Tschopp, M.D.; and Jason Zagrodzky, M.D.

Physicians will receive a maximum of 14 American Medical Association (AMA)

Physician's Recognition Award (PRA) Category 1 Credit™ hours at the conference.

 

 

EPLive 2022 also includes a special fellows program, EP Finishing School, on

June 4 and 5. The live practical course brings all major aspects of a

fellowship training program—hands-on training, research opportunities and

clinical materials—to a single platform and gives graduating fellows the unique

opportunity to learn how to solve clinical scenarios. Electrophysiology fellows

will watch up to 40 cases from the world's leading experts—with commentary

based on current evidence-driven management strategies—and have a presentation

in which they bring a case and defend it to an expert panel.

 

 

The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center is

one of the world's preeminent centers dedicated to the latest treatment

advances for correcting arrhythmias. The center is led by Dr. Natale, who is at

the forefront of advancing treatment for A Fib, leading numerous clinical

trials, and participating in the development of new technologies and procedures.

 

 

For more information, visit EP-Live.com.

 

 

Media Contact:

Matt Grilli or Kat Griffith, ECPR

MGrilli@EChristianPR.com or KGriffith@EChristianPR.com

630.800.9533 or 512.797.4002 cells

 

SOURCE Texas Cardiac Arrhythmia Institute at St. David's Medical Center

 

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中